Evidence map›Paper›PMID 38820330›Full record

ArticlePloS one2024

Uro-pathogens: Multidrug resistance and associated factors of community-acquired UTI among HIV patients attending antiretroviral therapy in Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.

Mihret Tilahun, Mesfin Fiseha, Mihreteab Alebachew, Alemu Gedefie, Endris Ebrahim, Melkam Tesfaye, Melaku Ashagrie Belete, Abdurahaman Seid, Daniel Gebretsadik, Ermiyas Alemayehu and 5 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Distribution and Drug-Resistance Analysis of Uropathogens in Urinary Tract Infections.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  4. Article
  5. Urinary tract infections in immunocompromised patients.Current opinion in infectious diseases · 2025
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mihret TilahunDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.ORCID 0000-0002-2343-2119
Mesfin FisehaDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.ORCID 0000-0001-6699-7323
Mihreteab AlebachewDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Alemu GedefieDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Endris EbrahimDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.ORCID 0000-0002-0808-0303
Melkam TesfayeDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Melaku Ashagrie BeleteDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Abdurahaman SeidDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Daniel GebretsadikDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Ermiyas AlemayehuDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.ORCID 0000-0002-0955-5817
Wondmagegn DemsissDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Bekele SharewDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.ORCID 0000-0001-7575-2387
Agumas ShibabawDepartment of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.
Habtamu MekonnenAmhara Public Health Institute Dessie Branch, Dessie, Ethiopia.
Tewodros DessieAmhara Public Health Institute Dessie Branch, Dessie, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary tract infections are common bacterial and fungal infections in humans, occurring both in the community and in immunocompromised patients in healthcare settings. Urinary tract infections have a significant health impact on HIV-infected patients. Nowadays, drug-resistant pathogens are widespread poses a serious clinical risk, and causes urinary tract infection. The common agents of bacteria and fungi that cause urinary tract infection are Escherichia coli followed by Klebsiella pneumonia, Staphylococcus saprophyticus, Enterococcus faecalis, group B streptococcus, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus and Candida. albicans. This study aimed to investigate uro-pathogen, multidrug resistance pattern of bacteria, and associated factors of community-acquired urinary tract infection among HIV-positive patients attending antiretroviral therapy in Dessie comprehensive specialized hospital, Northeast Ethiopia from February 1, 2021, to March 30, 2021.

methodsAn institutional-based cross-sectional study was conducted at Dessie Comprehensive Specialized Hospital. Socio-demographic and clinical data were collected by using structured questionnaires from HIV patients suspected of community-acquired urinary tract infections. About 10 ml of clean-catch midstream urine was collected and inoculated into Blood agar, MacConkey, and Cysteine lactose electrolyte deficient media. Yeasts were identified by using Gram stain, germ tube test, carbohydrate fermentation, assimilation tests, and chromogenic medium. Gram stain and biochemical tests were performed to identify isolates and an antimicrobial susceptibility pattern was performed on disc diffusion techniques. Data were entered and analyzed using SPSS version 25. Both bivariate and multivariable logistic regression analysis was performed and a P value of < 0.05 with an adjusted odds ratio with their 95% confidence interval (CI) was used as statistically significant associations.

resultsFrom the total 346 study participants, 92 (26.6%) were culture positive 75 (81.52%) were bacterial and 17 (18.48%) were fungal pathogens. From a total of 75 bacteria isolates 51(68%) were Gram-negative bacteria and the most commonly isolated bacteria were E. coli 16 (21.33%) followed by K. pneumoniae 11(14.67%) and enterococcus species 10(10.87. Of the 17 fungal isolates of fungi, 8(47.1%) were represented by C. tropicalis. Of the isolated bacteria, 61(81.3%) were resistant to three and above classes of antibiotics (drug classes). About 13 (81.3%) of E. coli, 9(81.8%) of K. pneumoniae, 8(80%) of Enterococcus species, 7 (77.8%) of P. aeruginosa, and CoNs 7(87.5%) were the most frequently exhibited three and above classes of antibiotics (multi-drug resistance). Amikacin and gentamicin were effective against Gram-negative Uro-pathogens. Participants aged>44year, female, being daily labor, being farmer, unable to read and write, patients with CD4 count of ≤ 200 cells/mm3 and CD4 count of 201-350 cells/mm3, who had chronic diabetics, patients having a history of hospitalization and who had urgency of urinations were statistically significant association with significant urinary tract infections.

conclusionThe burden of community-acquired urinary tract infections among HIV patients is alarmingly increased. Therefore, behavior change communications might be considered for promoting the health status of HIV patients. Moreover, CD4 level monitoring and therapeutics selection based on microbiological culture are quite advisable for the management of urinary tract infections of HIV patients.

Indexed as

Community-Acquired InfectionsHIV InfectionsUrinary Tract InfectionsAdultAnti-Bacterial AgentsBacteriaCross-Sectional StudiesDrug Resistance, Multiple, BacterialEthiopiaFemaleHospitals, SpecialHumansMaleMicrobial Sensitivity TestsMiddle AgedYoung AdultAnti-Bacterial Agents

Identifiers

PMID38820330
PMCPMC11142584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.